Ping An Tsumura Pharmaceutical

Ping An Tsumura Pharmaceutical is a strategic joint venture between the Japanese Kampo medicine leader Tsumura & Co. and the Chinese financial and healthcare giant Ping An Insurance Group. The company is dedicated to the modernization and standardization of Traditional Chinese Medicine (TCM) by combining Tsumura's century-long expertise in herbal manufacturing with Ping An's extensive healthcare ecosystem and digital infrastructure. Its operations encompass the entire TCM value chain, including the scientific cultivation of medicinal herbs, the production of high-quality TCM decoction pieces, and the manufacture of concentrated herbal granules. By implementing rigorous quality control systems and traceability from 'seed to patient,' Ping An Tsumura aims to establish itself as a premier provider of standardized TCM products in the Chinese market.